New England Journal of Medicine · 1975 · 175 citations · 41 references
MedicineEndocrinologyNuclear MedicinePediatric EndocrinologyRadionuclide TherapyTherapeutic Nuclear MedicineHyperthyroidism EvaluationPediatric Nuclear MedicineRadioiodine TherapyThyroid CancerThyroid DisordersThyroid Uptake StudiesGoiter RecurrenceGraves' Disease TreatmentLong-term CourseLong-term EffectivenessPediatric HypothyroidismPediatric Thyroid DiseasePediatric Thyroid DisordersRadioactive Iodine Therapy Care
To evaluate the long-term results of 131I therapy for children, we studied the course of 87 patients (three to 18 years old, 24 boys and 63 girls) treated from 1949 through 1968, for hyperthyroidism due to Graves's disease. Dose of 131I per patient ranged from 2.9 to 31 mCi (mean ± S.D., 9.75 ± 6.5). Patients were followed for five to 24 years (mean, 12.3±3.5). Hyperthyroidism was controlled in 85 within one to 14 months (mean, 3.3±2.6). Recurrence of thyrotoxicosis due to toxic diffuse goiter, observed in only one case after 11 years, was successfully re-treated with 131I. Reproductive history and health status of the progeny of 13lI-treated patients were not different from those of the general population. No deaths and no cancer or leukemia were observed in patients or their offspring. The major cause of goiter regrowth was Hashimoto's thyroiditis. Hypothyroidism developed in 35 of 76 patients (46 per cent). 131I deserves further use in treatment of hyperthyroid children with Graves's disease (N Engl J Med 292:167–171, 1975)
41
BROWN M. DOBYNS, Glenn E. Sheline, Joseph Workman et al. · The Journal of Clinical Endocrinology & Metabolism · 1974 · 392 citations
Thyroid cancer in childhood and adolescence.A report on twenty-eight cases
Benedict J. Duffy, Patrick Fitzgerald · Cancer · 1950 · 235 citations · Full text
Medicine, Oncology, Pediatrics +16
Probabilities of Fetal Mortality
Fern E. French, Jessie M. Bierman · Public Health Reports (1896-1970) · 1962 · 209 citations